Status:
COMPLETED
The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm
Lead Sponsor:
Applied Science Private University
Conditions:
Cytokine Storm
Cytokines
Eligibility:
All Genders
30-66 years
Phase:
NA
Brief Summary
The trial was designed to assess the effect of daily dose of 300 mg omega-3 supplements for 2 months on the selected interleukins levels in uninfected people with Covid-19.
Detailed Description
Omega-3 Fatty Acids (Omega-3) are long poly unsaturated fatty acids that can be found in plants and fish, its refer to a group composed of three type of fatty acids called: Eicosapentaenoic acid (EPA)...
Eligibility Criteria
Inclusion
- Inclusion criteria included males and females in the age range of 30-66 years without a medical diagnosis of COVID-19 infection.
Exclusion
- Exclusion criteria included males or females diagnosed with any chronic immune problems, including autoimmune diseases, chronic or severe infections.
- Pregnant, breastfeeding, and females using hormonal contraceptives were also excluded.
Key Trial Info
Start Date :
October 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04483271
Start Date
October 2 2020
End Date
February 28 2021
Last Update
February 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud S Abu-Samak
Amman, Jordan